远程医疗公司Hims & Hers Health Inc.(HIMS.N)的股价在周一盘中大涨6.94%,市场对一项重大人事任命反应积极,助推股价攀升。
消息面上,Hims & Hers Health周一宣布,任命前美国食品药品监督管理局(FDA)副局长Deb Autor进入公司董事会。Autor在2011年至2013年期间曾负责监督FDA的检查和国际业务,并担任过药物评估与研究中心合规办公室主任。市场认为,其加入将有助于公司在医药法规合规方面取得优势,保障公司业务长远发展。
与此同时,Hims & Hers Health也新任命一名来自百特(BAX.N)的资深人士Janet Stevens担任公司全球质量与安全主管。这两项人事变动反映了公司在强化内控与质量管理方面的决心,进一步增强了市场对Hims & Hers Health未来前景的信心,推动盘中股价大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.